
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-5190
Fax+1 617-732-5706
Dr. Bianchi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
- Universita San RaffaeleClass of 2006
Certifications & Licensure
- MA State Medical License 2012 - 2025
- MN State Medical License 2011 - 2012
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment.Nicolas A Gort-Freitas, Maria Moscvin, Matteo Claudio Da Viá, Francesca Lazzaroni, Alice Nevone
Blood. 2025-06-10 - Cardiac Amyloidosis in Older Adults With a Focus on Frailty: JACC: Advances Expert Consensus.Nicole K Bart, Giada Bianchi, Sarah A M Cuddy, Parag Goyal, Jan M Griffin
JACC. Advances. 2025-06-01 - Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based Regimens.Brendan Saunders, Foteini Theodorakakou, Despina V Fotiou, Samuel Boullt, Benjamin Evans
Blood Advances. 2025-04-30
Abstracts/Posters
- Targeting Myeloma Cell Metabolism Via Disruption of the Lnc-17-92 Transcriptional Program: Druggable New Vulnerability in Multiple MyelomaGiada Bianchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase II Study of Elotuzumab in Combination with Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple MyelomaGiada Bianchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Loss-of-Function of Gabarap Impairs Bortezomib-Induced Anti-Tumor Immunity in Multiple Myeloma: Clinical ApplicationGiada Bianchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- The Economic Effects of the Coronavirus May Kill More Americans Than the Virus ItselfJanuary 25th, 2021
- Administered Earlier, Cilta-Cel CAR T Produces Deep, Durable Responses in Multiple Myeloma PatientsDecember 9th, 2023
Grant Support
- Functional Consequences of Ubiquitin Depletion During B Lymphocyte DifferentiationBRIGHAM AND WOMEN'S HOSPITAL2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: